Perioperative care of a child with ullrich congenital muscular dystrophy

Middle East Journal of Anesthesiology

Volumn 20, Issue 2, 2009, Pages 319-324

  Puangsuvan, Neesann ^a   Mester, Robert A ^a   Ramachandran, Venkataraman ^b   Tobias, Joseph D ^b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTRAVENOUS ANESTHETIC AGENT; PIPERIDINE DERIVATIVE; PROPOFOL; REMIFENTANIL;

APPENDECTOMY; APPENDICITIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; METHODOLOGY; MUSCULAR DYSTROPHY; PERIOPERATIVE PERIOD; PRESCHOOL CHILD; RUPTURE;

ANESTHETICS, INTRAVENOUS; APPENDECTOMY; APPENDICITIS; CHILD, PRESCHOOL; FEMALE; HUMANS; MUSCULAR DYSTROPHIES; PERIOPERATIVE CARE; PIPERIDINES; PROPOFOL; RUPTURE, SPONTANEOUS;

EID: 67650503128     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Brockington M, Brown SC, Feng L, et al: Collagen VI involvement in Ullrich syndrome: a clinical genetic, and immunohistochemical study. Neurology; 2002, 58:1354-9.
2. Lampe AK, Bushby KMD: Collagen VI related muscle disorders. J Med Gen; 2005, 42;673-685.
3. Kuo HJ, Maslen CL, Keene DR, Glanville RW: Type VI Collagen anchors endothelial basement membranes by interacting with type IV collagen. J Bio Chem; 1997, 272:26522-26529.
4. Ruhl M, Sahin E, Johannsen M, et al: Soluble collagen VI drives serum-starved fibroblasts through S-phase and prevents apoptosis via down-regulation of Bax. J Biol Chem; 1999, 274:34361-8.
5. Ruhl M, Johannsen M, Atkinson J, et al: Soluble collagen VI induces tyrosine phosphorylation of paxillin and focal adhesion kinase and activates the MAP kinase erk2 in fibroblasts. Exp Cell Res; 1999, 250:548-557.
6. Howell SJ, Doane KJ: Type VI collagen increases cell survival and prevents anti-beta 1 integrin-mediated apoptosis. Exp Cell Res; 1998, 241:230-241.
7. Miller ED Jr, Sanders DB, Rowlingson JC, et al: Anesthesiainduced rhabdomyolysis in a patient with Duchenne muscular dystrophy. Anesthesiology; 1978, 48:146-148.
8. Sethna NF, Rockoff MA, Worthern HM, et al: Anesthesia-related complications in children with Duchenne muscular dystrophy. Anesthesiology; 1988, 68:462-465.
9. Buzello W, Huttarsch H: Muscle relaxation in patients with Duchenne's muscular dystrophy. Br J Anaesth; 1988, 60:228-231.
10. Huang FY, Sun WZ, Wang KC, Pai SY: Increased sensitivity to atracurium in a child with Duchenne's muscular dystrophy. Anaesth Sinica; 1990, 28:223-228.
11. Frankowski GA, Johnson JO, Tobias JD: Rapacuronium administration to two children with Duchenne muscular dystrophy. Anesth Analg; 2000, 91:27-28.
12. Tobias JD, Atwood R: Mivacurium in children with Duchenne muscular dystrophy. Paediatr Anaesth; 1994, 4:57-60.
13. Batra YK, AL Qattan AR, Ali SS, et al: Assessment of tracheal intubating conditions using remifentanil and propofol without muscle relaxant. Pediatr Anesth; 2004, 14:452-456.
14. Stevens JB, Wheatley L: Tracheal intubation in ambulatory surgery patients using remifentanil and propofol without muscle relaxants. Anesth Analg; 1998, 86:45-49.
15. Alexander R, Olufolabi AJ, Booth J, et al: Dosing study of remifentanil and propofol for tracheal intubation without the use muscle relaxants. Anaesthesia; 1999, 54:1037-1040.
16. Politis GD, Tobias JD: Rapid sequence intubation without a neuromuscular blocking agent in a 14-year-old female patient with myasthenia gravis. Pediatr Anesth; 2007, 17:285-288.
17. Jones D, Cone A: Management of a difficult airway in a patient with Duchenne's muscular dystrophy. Br J Hosp Med; 1997, 58:410-412.
18. Aldwinckle RJ, Carr AS: The anesthetic management of a patient with Emery-Dreifuss muscular dystrophy for orthopedic surgery. Can J Anesth; 2002, 49:467-470.
19. Tobias JD, Holcomb GW III, Brock JW III, et al: Analgesia after inguinal herniorrhaphy with laparoscopic inspection of the peritoneum in children. Am J Anesthesiol; 1995, 22:193-197.